<?xml version="1.0" encoding="UTF-8"?>
<ref id="b0435">
 <label>87</label>
 <element-citation publication-type="journal" id="h0435">
  <person-group person-group-type="author">
   <name>
    <surname>Hung</surname>
    <given-names>I.F.</given-names>
   </name>
   <name>
    <surname>Lung</surname>
    <given-names>K.C.</given-names>
   </name>
   <name>
    <surname>Tso</surname>
    <given-names>E.Y.</given-names>
   </name>
   <name>
    <surname>Liu</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Chung</surname>
    <given-names>T.W.</given-names>
   </name>
   <name>
    <surname>Chu</surname>
    <given-names>M.Y.</given-names>
   </name>
  </person-group>
  <article-title>Triple combination of interferon beta-1b, lopinavirâ€“ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial</article-title>
  <source>Lancet</source>
  <volume>395</volume>
  <issue>10238</issue>
  <year>2020</year>
  <fpage>1695</fpage>
  <lpage>1704</lpage>
  <pub-id pub-id-type="pmid">32401715</pub-id>
 </element-citation>
</ref>
